Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Immunoblastic Lymphadenopathy × spartalizumab × 90 days × Clear all

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 3 Uterine Cervical Neoplasms 2 Pancreatic Neoplasms 2 Neoplasm Metastasis 2 Nasopharyngeal Carcinoma 2 Colorectal Neoplasms 2 Carcinoma, Renal Cell 2 von Hippel-Lindau Disease 1 Triple Negative Breast Neoplasms 1 Stomach Neoplasms 1 Solid Tumors 1 Solid Tumor, Adult 1 Rectal Neoplasms 1 Prostatic Neoplasms 1 Pheochromocytoma 1 Paraganglioma 1 Nasopharangeal Cancer 1 Myelodysplastic Syndromes 1 Melanoma 1 Locally Advanced Rectal Cancer 1 Leukemia, Myelomonocytic, Chronic 1 Kidney Neoplasms 1 Kidney Diseases 1 Hereditary leiomyomatosis and renal cell cancer 1 Glioma 1 Endometrial Neoplasms 1 Diffuse Intrinsic Pontine Glioma 1 Colonic Neoplasms 1 Advanced Malignant Tumors 1 Advanced Malignant Solid Neoplasm 1

Interventions

Cyclophosphamide 2 tazemetostat 1 romidepsin 1 pembrolizumab 1 glofitamab 1 fludarabine 1 etoposide phosphate 1 duvelisib 1 brincidofovir 1 belinostat 1 Vincristine 1 Valganciclovir 1 Therapeutics 1 Prednisone 1 Prednisolone 1 Polymerase Chain Reaction 1 Melphalan 1 Lactones 1 Gemcitabine 1 Ganciclovir 1 Foscarnet 1 Flow Cytometry 1 Etoposide 1 Doxorubicin 1 Depsipeptides 1 Cytarabine 1 Cholecalciferol 1 Carmustine 1 Bendamustine Hydrochloride 1 Azacitidine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡